colgate-palmolive co (CL) Key Developments
Colgate-Palmolive Company Declares Quarterly Cash Dividend, Payable on August 14, 2015
Jun 11 15
The Board of Directors of Colgate-Palmolive Company declared a quarterly cash dividend of $0.38 per common share, payable on August 14, 2015, to shareholders of record on July 23, 2015.
Colgate-Palmolive Co. Presents at Deutsche Bank db Access Global Consumer Conference 2015, Jun-09-2015 12:00 PM
Jun 2 15
Colgate-Palmolive Co. Presents at Deutsche Bank db Access Global Consumer Conference 2015, Jun-09-2015 12:00 PM. Venue: Paris, France. Speakers: Franck J. Moison, Chief Operating Officer of Emerging Markets & Business Development.
Colgate-Palmolive Company Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015
Apr 30 15
Colgate-Palmolive Company announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported net sales of $4,070 million against $4,325 million a year ago. Operating profit was $860 million against $634 million a year ago. Income before income taxes was $852 million against $627 million a year ago. Net income attributable to Colgate-Palmolive Company was $542 million or $0.59 per diluted share against $388 million or $0.42 per diluted share a year ago. Net cash provided by operations was $727 million compared to $820 million in the comparable 2014 period, primarily due to lower operating earnings and an increase in tax receivables. Capital expenditures were $122 million against $168 million a year ago. Operating profit, non-GAAP was $960 million against $1,003 million a year ago. Net income attributable to Colgate-Palmolive Company non-GAAP was $609 million or $0.66 per diluted share against $636 million or $0.68 per diluted share a year ago.
Colgate-Palmolive Hit with $13 Million Mesothelioma Verdict in California
Apr 29 15
Simon Greenstone Panatier Bartlett, PC have won a $13 million jury verdict on behalf of a 73-year-old woman who contracted mesothelioma after using asbestos-containing talcum powder manufactured by Colgate-Palmolive Company. The April 28 verdict was handed down by a jury in Los Angeles Superior Court following only two hours of deliberations. Jurors assigned 95% liability against Colgate-Palmolive based on plaintiff Judith Winkel's claims that the company's talcum powder products caused her to contract mesothelioma, a fatal lung disease. Ms. Winkel was diagnosed with mesothelioma in January 2014 after using Cashmere Bouquet manufactured by Colgate-Palmolive. Most people who are diagnosed with mesothelioma die within two years of diagnosis, says Simon Greenstone name shareholder Chris Panatier, who represented Ms. Winkel and her husband, John. The jury unanimously found in favor of Ms. Winkel and her husband on five counts: consumer expectations, risk-benefit, manufacturing defect, failure to warn and negligence. The jury also found that Colgate-Palmolive acted with malice. Following the verdict, the parties reached a confidential settlement before the trial's punitive damages phase was set to begin.
Colgate-Palmolive Co. - Shareholder/Analyst Call
Apr 24 15
2015 Annual Meeting of Stockholders